{"name": "Proximagen",
 "permalink": "proximagen",
 "crunchbase_url": "http://www.crunchbase.com/company/proximagen",
 "homepage_url": "http://www.proximagen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Neuroscience Research Company",
 "created_at": "Wed Jun 17 22:25:24 UTC 2009",
 "updated_at": "Fri Sep 30 02:44:16 UTC 2011",
 "overview": "\u003Cp\u003EProximagen is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson\u0026#8217;s disease and Alzheimer\u0026#8217;s disease.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0004/9242/49242v1-max-150x150.png"],
     [[210,
       55],
      "assets/images/resized/0004/9242/49242v1-max-250x250.png"],
     [[210,
       55],
      "assets/images/resized/0004/9242/49242v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$96.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/proximagen-rounds-80-5m-cns-deals/2009-06-05?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Proximagen rounds up $80.5M for CNS deals",
    "raised_amount": 80500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 5,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/proximagen-polishes-its-cns-rep-16m-lundbeck-deal/2011-09-29?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Proximagen polishes its CNS rep with $16M Lundbeck deal",
    "raised_amount": 16000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 29,
    "investments":
     [{"company":
        {"name": "Lundbeck",
         "permalink": "lundbeck",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0004/8012/48012v1-max-150x150.png"],
             [[210,
               81],
              "assets/images/resized/0004/8012/48012v1-max-250x250.png"],
             [[210,
               81],
              "assets/images/resized/0004/8012/48012v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Corporate Headquarters",
    "address1": "Hodgkin Building",
    "address2": "Guy's Campus",
    "zip_code": "SE1 1UL ",
    "city": "London",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}